Promising phase II data presented for AK-002 in Xolair-naive chronic spontaneous urticaria patients Jan. 8, 2019 No Comments
Life Science Institute initiates exploratory clinical trial of CL-2020 in epidermolysis bullosa Dec. 24, 2018 No Comments
Corbus initiates phase III DETERMINE study based on phase II data in dermatomyositis Dec. 19, 2018 No Comments
Aclaris offers update on clinical trials of JAK1/3 inhibitors ATI-502 and ATI-501 Dec. 18, 2018 No Comments
RSS